One-Time CRISPR Treatment Holds Down Monkey Triglycerides for Three Years
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources
Brief
Researchers at Verve Therapeutics, an Eli Lilly subsidiary, report in the journal Nature that switching off a liver gene…
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
4 confirmed facts, 2 open questions and 2 sources behind this story.